ESTRING Side Effects

7023075-2 | Diplopia
on Sep 18, 2010 Female patient from UNITED STATES , weighting 169.8 lb, was treated with Estring (View Usage). Patient experienced the following unwanted or unexpected effects: diplopia. Estring dosage: 2 Mg, Unk.

7022948-4 | Condition Aggravated, Genital Rash, Vaginal Lesion, Vaginal Swelling, Vulvovaginal Discomfort, Vulvovaginal Mycotic Infection, Vulvovaginal Pain, Vulvovaginal Pruritus
Patient was taking Estring (View Usage). Patient had the following side effects: condition aggravated, genital rash, vaginal lesion, vaginal swelling, vulvovaginal discomfort, vulvovaginal mycotic infection, vulvovaginal pain, vulvovaginal pruritus on Sep 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 136.0 lb, was diagnosed with off label use, cystocele and. Estring dosage: Unk.

7008550-9 | Alopecia
Adverse event was reported on Sep 14, 2010 by a Female patient taking Estring (View Usage) (Dosage: 2 Mg, Unk) was diagnosed with vulvovaginal dryness, osteoporosis (What is osteoporosis?) and. Location: UNITED STATES , weighting 178.6 lb, After Estring was administered, patient had the following side effects: alopecia. During the same period patient was treated with ALENDRONATE SODIUM (70 Mg, Weekly) (View Alendronate Sodium Review and Alendronate Sodium Label ).

7008535-2 | Dyspareunia
on Aug 30, 2010 Female patient from UNITED STATES , weighting 200.0 lb, was diagnosed with menopausal symptoms, atrophic vulvovaginitis and was treated with Estring (View Usage). Patient experienced the following unwanted or unexpected effects: dyspareunia. Estring dosage: 2 Mg, Unk.


7006298-8 | Headache, Heart Rate Increased, Pyrexia
on Sep 09, 2010 Female patient from UNITED STATES , 56 years of age, was treated with Estring (View Usage). Patient had the following side effects: headache (What is headache?), heart rate increased, pyrexia. Estring dosage: 2 Mg, Every 3 Months.

6991729-X | Insomnia, Vulvovaginal Pain
Patient was taking Estring (View Usage). After Estring was administered, patient had the following side effects: insomnia, vulvovaginal pain on Aug 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with atrophic vulvovaginitis and. Estring dosage: Unk.

6988860-1 | Incorrect Dose Administered
Adverse event was reported on Aug 12, 2010 by a Female patient taking Estring (View Usage) (Dosage: 2 Mg, Unk) was diagnosed with atrophic vulvovaginitis, hypertension, blood cholesterol increased and. Location: UNITED STATES , weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: incorrect dose administered. During the same period patient was treated with TRIAMTERENE (37.5 Mg, 1x/day) (View Triamterene Review and Triamterene Label ), GEMFIBROZIL (600 Mg, 2x/day) (View Gemfibrozil Review and Gemfibrozil Label ).

6977215-1 | Breast Engorgement, Breast Pain, Breast Tenderness, Hot Flush, Hyperhidrosis, Nipple Pain, Poor Quality Sleep
on Jul 29, 2010 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with vulvovaginal dryness, atrophic vulvovaginitis and was treated with Estring (View Usage). Patient had the following side effects: breast engorgement, breast pain, breast tenderness, hot flush, hyperhidrosis, nipple pain, poor quality sleep. Estring dosage: 2 Mg, Every 3 Months.

6967659-6 | Vulvovaginal Burning Sensation, Vulvovaginal Mycotic Infection, Vulvovaginal Pruritus
on Aug 27, 2010 Female patient from UNITED STATES , weighting 114.6 lb, was diagnosed with vulvovaginal dryness and was treated with Estring (View Usage). After Estring was administered, patient had the following side effects: vulvovaginal burning sensation, vulvovaginal mycotic infection, vulvovaginal pruritus. Estring dosage: Unk. During the same period patient was treated with SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ).

6960907-8 | Vulvovaginal Mycotic Infection
Patient was taking Estring (View Usage). Patient experienced the following unwanted or unexpected effects: vulvovaginal mycotic infection on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 158.0 lb, was diagnosed with atrophic vulvovaginitis, dyspareunia, hypothyroidism, migraine (What is migraine?), osteoporosis prophylaxis and. Estring dosage: 2 Mg, Unk. During the same period patient was treated with LEVOTHYROXINE (Unk) (View Levothyroxine Review and Levothyroxine Label ), RANITIDINE (Unk) (View Ranitidine Review and Ranitidine Label ), TOPIRAMATE (Unk) (View Topiramate Review and Topiramate Label ), RELPAX (Unk, As Needed) (View Relpax Review and Relpax Label ), MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ), VITAMIN D (Unk) (View Vitamin D Review and Vitamin D Label ).

6960903-0 | Hot Flush
Adverse event was reported on Jul 28, 2010 by a Female patient taking Estring (View Usage) (Dosage: Unk) . Location: UNITED STATES , weighting 180.0 lb, Patient had the following side effects: hot flush.

6956629-X | Bowel Movement Irregularity, Constipation, Insomnia, Irritability
on Aug 04, 2010 Female patient from UNITED STATES , weighting 119.0 lb, was diagnosed with hot flush, vulvovaginal dryness, atrophic vulvovaginitis and was treated with Estring (View Usage). After Estring was administered, patient had the following side effects: bowel movement irregularity, constipation (What is constipation?), insomnia, irritability. Estring dosage: Frequency: Every 3 Months.

6944442-9 | Blood Glucose Increased, Memory Impairment, Speech Disorder, Vision Blurred
on Aug 16, 2010 Female patient from UNITED STATES , weighting 153.9 lb, was diagnosed with atrophic vulvovaginitis and was treated with Estring (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, memory impairment, speech disorder, vision blurred. Estring dosage: Unk. During the same period patient was treated with PREMARIN (0.3 Mg, Unk) (View Premarin Review and Premarin Label ), CRESTOR (5 Mg, 2x/week) (View Crestor Review and Crestor Label ), SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ).

6941943-4 | Coeliac Disease, Vulvovaginal Mycotic Infection
Patient was taking Estring (View Usage). Patient had the following side effects: coeliac disease, vulvovaginal mycotic infection on Aug 16, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with vulvovaginal dryness, depression (What is depression?), sleep disorder (What is sleep disorder?) and. Estring dosage: 2 Mg, Unk. During the same period patient was treated with PROZAC (Unk) (View Prozac Review and Prozac Label ), LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ), PRAZOSIN (Unk) (View Prazosin Review and Prazosin Label ).

6932232-2 | Lipase Increased, Vaginal Discharge
Adverse event was reported on Aug 09, 2010 by a Female patient taking Estring (View Usage) (Dosage: 7.5 Ug, Unk) was diagnosed with menopausal symptoms and. Location: UNITED STATES , weighting 125.0 lb, After Estring was administered, patient had the following side effects: lipase increased, vaginal discharge. Patient was hospitalized.

6928470-5 | Abdominal Distension, Breast Pain, Burning Sensation, Headache, Hypertension, Muscle Spasms, Vulvovaginal Discomfort
on Aug 10, 2010 Female patient from UNITED STATES , weighting 149.0 lb, was diagnosed with vulvovaginal dryness, hypothyroidism and was treated with Estring (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, breast pain, burning sensation, headache (What is headache?), hypertension, muscle spasms, vulvovaginal discomfort. Estring dosage: Unk. During the same period patient was treated with SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ), VITAMIN D (Unk) (View Vitamin D Review and Vitamin D Label ), FISH OIL (Unk) (View Fish Oil Review and Fish Oil Label ).

6920938-0 | Hypersensitivity, Urticaria, Vulval Oedema
on Aug 02, 2010 Female patient from CANADA , 54 years of age, was diagnosed with vulvovaginal dryness, back pain (What is back pain?), hypersensitivity and was treated with Estring (View Usage). Patient had the following side effects: hypersensitivity, urticaria, vulval oedema. Estring dosage: 2mg Every 90 Days. During the same period patient was treated with ACETAMINOPHEN (Unk) (View Acetaminophen Review and Acetaminophen Label ), RIVOTRIL (Unk) (View Rivotril Review and Rivotril Label ), FLOVENT (As Needed) (View Flovent Review and Flovent Label ).

6914134-0 | Insomnia, Muscle Spasms
Patient was taking Estring (View Usage). After Estring was administered, patient had the following side effects: insomnia, muscle spasms on Jul 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 108.0 lb, was diagnosed with vulvovaginal dryness, mineral supplementation and. Estring dosage: Unk. During the same period patient was treated with LEVOXYL (112 Ug, 1x/day) (View Levoxyl Review and Levoxyl Label ), POTASSIUM (Unk) (View Potassium Review and Potassium Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ).

6882764-0 | Arthralgia, Decreased Appetite, Fatigue, Myalgia, Myxoedema, Oedema Peripheral, Varicose Vein
Adverse event was reported on Jul 20, 2010 by a Female patient taking Estring (View Usage) (Dosage: 7.5 Ug, Every 3 Months) was diagnosed with vulvovaginal dryness, myxoedema, osteoporosis (What is osteoporosis?) and. Location: DENMARK , 62 years of age, weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, decreased appetite, fatigue, myalgia, myxoedema, oedema peripheral, varicose vein (What is varicose vein?). During the same period patient was treated with ELTROXIN (125 Ug, 1x/day) (View Eltroxin Review and Eltroxin Label ), ALENDRONIC ACID (70 Mg, Weekly) (View Alendronic Acid Review and Alendronic Acid Label ).

6879735-7 | Urinary Tract Infection, Vulvovaginal Burning Sensation, Vulvovaginal Discomfort
on Mar 10, 2010 Female patient from UNITED STATES , 65 years of age, was treated with Estring (View Usage). Patient had the following side effects: urinary tract infection (What is urinary tract infection?), vulvovaginal burning sensation, vulvovaginal discomfort. Estring dosage: Vaginal. Patient was hospitalized.

6879695-9 | Vulvovaginal Dryness, Vulvovaginitis
on Apr 12, 2010 Female patient from UNITED STATES , 56 years of age, weighting 110.0 lb, was diagnosed with atrophic vulvovaginitis and was treated with Estring (View Usage). After Estring was administered, patient had the following side effects: vulvovaginal dryness, vulvovaginitis. Estring dosage: 2 Mg, Every 3 Months, Vaginal.

6879680-7 | Breast Cancer
Patient was taking Estring (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?) on Jan 06, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 269.8 lb, was diagnosed with vulvovaginal dryness and. Estring dosage: 2 Mg, Vaginal. During the same period patient was treated with VIVELLE DOT (Transdermal) (View Vivelle-dot Review and Vivelle-dot Label ).

6879678-9 | Myocardial Infarction, Troponin T Increased
Adverse event was reported on Dec 01, 2009 by a Female patient taking Estring (View Usage) (Dosage: ) . Location: UNITED STATES , 55 years of age, weighting 130.1 lb, Patient had the following side effects: myocardial infarction, troponin t increased. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), PAXIL (View Paxil Review and Paxil Label ), SECTRAL (View Sectral Review and Sectral Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

6879661-3 | Back Pain, Pain In Extremity, Thrombosis
on Nov 12, 2009 Female patient from UNITED STATES , 58 years of age, weighting 129.9 lb, was diagnosed with vulvovaginal dryness and was treated with Estring (View Usage). After Estring was administered, patient had the following side effects: back pain (What is back pain?), pain in extremity, thrombosis. Estring dosage: 2 Mg. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TOPAMAX (View Topamax Review and Topamax Label ), BENTYL (View Bentyl Review and Bentyl Label ).

6879660-1 | Abdominal Distension, Hot Flush, Weight Increased
on Sep 23, 2009 Female patient from UNITED STATES , 54 years of age, weighting 145.1 lb, was diagnosed with vulvovaginal dryness and was treated with Estring (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, hot flush, weight increased. Estring dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CYTOMEL (View Cytomel Review and Cytomel Label ).

6879659-5 | Breast Engorgement, Breast Enlargement, Breast Tenderness, Thrombophlebitis Superficial
Patient was taking Estring (View Usage). Patient had the following side effects: breast engorgement, breast enlargement, breast tenderness, thrombophlebitis superficial on Oct 26, 2009 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with vulvovaginal dryness and. Estring dosage: 2 Mg, Vaginal; 2mg Vaginal. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

6879614-5 | Breast Cancer Female
Adverse event was reported on Jul 13, 2009 by a Female patient taking Estring (View Usage) (Dosage: ) . Location: UNITED STATES , 56 years of age, weighting 200.6 lb, After Estring was administered, patient had the following side effects: breast cancer female. During the same period patient was treated with PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6879608-X | Migraine
on Jul 31, 2009 Female patient from UNITED STATES , 60 years of age, weighting 121.3 lb, was treated with Estring (View Usage). Patient experienced the following unwanted or unexpected effects: migraine (What is migraine?). Estring dosage: 2 Mg, Every 3 Months, Vaginal.

6879606-6 | Breast Cancer Female
on Dec 03, 2009 Female patient from UNITED STATES , 57 years of age, weighting 123.5 lb, was treated with Estring (View Usage). Patient had the following side effects: breast cancer female. Estring dosage: 2 Mg, Vaginal. During the same period patient was treated with PREMARIN (Vaginal) (View Premarin Review and Premarin Label ), PREMPRO (0.625/2.5mg) (View Prempro Review and Prempro Label ), LOPRESSOR (METROPROLOL TARTRATE) (View Lopressor (metroprolol Tartrate) Review and Lopressor (metroprolol Tartrate) Label ).

6831314-3 | Chest Discomfort, Cough, Dysuria, Gastrooesophageal Reflux Disease, Menorrhagia, Uterine Leiomyoma
Patient was taking Estring (View Usage). After Estring was administered, patient had the following side effects: chest discomfort, cough, dysuria, gastrooesophageal reflux disease, menorrhagia, uterine leiomyoma on Jul 06, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 125.0 lb, was diagnosed with vulvovaginal disorder, urinary tract infection (What is urinary tract infection?), basedow's disease and. Estring dosage: 2mg, Every 3 Months. During the same period patient was treated with TAPAZOLE (Unk) (View Tapazole Review and Tapazole Label ).

6817652-9 | Blood Glucose Increased, Memory Impairment, Speech Disorder, Vision Blurred
Adverse event was reported on Jun 29, 2010 by a Female patient taking Estring (View Usage) (Dosage: Unk) . Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, memory impairment, speech disorder, vision blurred. During the same period patient was treated with PREMARIN (0.3 Mg, Unk) (View Premarin Review and Premarin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6812994-5 | Irritability, Muscle Spasms, Nausea, Pain, Tension
on Jun 24, 2010 Female patient from UNITED STATES , weighting 157.0 lb, was treated with Estring (View Usage). Patient had the following side effects: irritability, muscle spasms, nausea (What is nausea?), pain (What is pain?), tension. Estring dosage: Unk.

6811139-5 | Adnexa Uteri Pain, Arthritis, Hypertonic Bladder, Rash Pruritic
on Oct 26, 2009 Female patient from UNITED STATES , weighting 165.3 lb, was diagnosed with atrophic vulvovaginitis, vulvovaginal dryness, genital herpes, arthritis (What is arthritis?), thyroid neoplasm and was treated with Estring (View Usage). After Estring was administered, patient had the following side effects: adnexa uteri pain, arthritis (What is arthritis?), hypertonic bladder, rash pruritic. Estring dosage: Unk. During the same period patient was treated with MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), LYSINE (View Lysine Review and Lysine Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), UBIDECARENONE (View Ubidecarenone Review and Ubidecarenone Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6811135-8 | Vulvovaginal Pruritus
Patient was taking Estring (View Usage). Patient experienced the following unwanted or unexpected effects: vulvovaginal pruritus on Apr 03, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 145.1 lb, was diagnosed with vulvovaginal dryness and. Estring dosage: 2 Mg, 1x/day. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

6811128-0 | Vulvovaginal Discomfort
Adverse event was reported on Apr 07, 2009 by a Female patient taking Estring (View Usage) (Dosage: Unk) was diagnosed with atrophic vulvovaginitis, gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 160.1 lb, Patient had the following side effects: vulvovaginal discomfort. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ).

6811120-6 | Bone Pain, Migraine, Vulvovaginal Discomfort, Vulvovaginal Mycotic Infection
on Mar 15, 2010 Female patient from UNITED STATES , weighting 168.9 lb, was diagnosed with menopause (What is menopause?), migraine (What is migraine?) and was treated with Estring (View Usage). After Estring was administered, patient had the following side effects: bone pain, migraine (What is migraine?), vulvovaginal discomfort, vulvovaginal mycotic infection. Estring dosage: 2 Mg, Unk. During the same period patient was treated with VAGIFEM (View Vagifem Review and Vagifem Label ), SUMATRIPTAN SUCCINATE (IMITREX) (View Sumatriptan Succinate (imitrex) Review and Sumatriptan Succinate (imitrex) Label ).

6811114-0 | Metrorrhagia, Pelvic Pain
on Apr 10, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with vaginal infection, vulvovaginal dryness and was treated with Estring (View Usage). Patient experienced the following unwanted or unexpected effects: metrorrhagia, pelvic pain (What is pelvic pain?). Estring dosage: Unk. During the same period patient was treated with SERTRALINE HYDROCHLORIDE (Unk) (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), CONCERTA (Unk) (View Concerta Review and Concerta Label ), MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ).

6811113-9 | Abdominal Distension, Dysphagia, Eructation
Patient was taking Estring (View Usage). Patient had the following side effects: abdominal distension, dysphagia, eructation on Jun 16, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 170.0 lb, was diagnosed with postmenopause, vulvovaginal dryness, oesophagitis, chronic sinusitis and. Estring dosage: Unk. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), MUCINEX (View Mucinex Review and Mucinex Label ).

6811087-0 | Erythema, Vaginal Swelling, Vulvovaginal Discomfort
Adverse event was reported on Apr 21, 2009 by a Female patient taking Estring (View Usage) (Dosage: Unk) was diagnosed with postmenopause, breast cancer (What is breast cancer?), sleep disorder (What is sleep disorder?) and. Location: UNITED STATES , weighting 149.9 lb, After Estring was administered, patient had the following side effects: erythema, vaginal swelling, vulvovaginal discomfort. During the same period patient was treated with ALPRAZOLAM (Unk) (View Alprazolam Review and Alprazolam Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6811082-1 | Chest Discomfort, Cough, Dysuria, Gastrooesophageal Reflux Disease
on Jun 16, 2009 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with vulvovaginal disorder, urinary tract infection (What is urinary tract infection?) and was treated with Estring (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, cough, dysuria, gastrooesophageal reflux disease. Estring dosage: Frequency: Every 3 Months;. During the same period patient was treated with TAPAZOLE (Unk) (View Tapazole Review and Tapazole Label ).

6811079-1 | Abdominal Distension, Nausea
on Jun 17, 2009 Female patient from UNITED STATES , weighting 155.0 lb, was diagnosed with vaginal disorder and was treated with Estring (View Usage). Patient had the following side effects: abdominal distension, nausea (What is nausea?). Estring dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

6811061-4 | Application Site Discomfort, Application Site Pain, Pelvic Pain
Patient was taking Estring (View Usage). After Estring was administered, patient had the following side effects: application site discomfort, application site pain, pelvic pain (What is pelvic pain?) on Dec 12, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 130.3 lb, was diagnosed with menopause (What is menopause?), atrophic vulvovaginitis and. Estring dosage: . During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ).

6811057-2 | Cystitis, Hypertension, Pollakiuria, Vulvovaginal Discomfort
Adverse event was reported on Feb 18, 2009 by a Female patient taking Estring (View Usage) (Dosage: Unk) was diagnosed with bladder prolapse and. Location: UNITED STATES , weighting 119.9 lb, Patient experienced the following unwanted or unexpected effects: cystitis, hypertension, pollakiuria, vulvovaginal discomfort. During the same period patient was treated with LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ), DETROL (Unk) (View Detrol Review and Detrol Label ), PREMARIN (Unk) (View Premarin Review and Premarin Label ), NITROFURANTOIN (Unk) (View Nitrofurantoin Review and Nitrofurantoin Label ), PRILOSEC (Unk) (View Prilosec Review and Prilosec Label ), ZETIA (Unk) (View Zetia Review and Zetia Label ).

6811052-3 | Back Pain
on Jan 28, 2009 Female patient from UNITED STATES , weighting 119.9 lb, was diagnosed with vulvovaginal dryness and was treated with Estring (View Usage). Patient had the following side effects: back pain (What is back pain?). Estring dosage: .

6811049-3 | Vaginal Discharge, Vulvovaginal Mycotic Infection
on Mar 09, 2009 Female patient from UNITED STATES , weighting 120.4 lb, was diagnosed with vulvovaginal dryness and was treated with Estring (View Usage). After Estring was administered, patient had the following side effects: vaginal discharge, vulvovaginal mycotic infection. Estring dosage: 2 Mg, Every 3 Months. During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ).

6811044-4 | Papilloma Viral Infection, Post Procedural Haemorrhage
Patient was taking Estring (View Usage). Patient experienced the following unwanted or unexpected effects: papilloma viral infection, post procedural haemorrhage on Jan 23, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with vulvovaginal dryness, vulvovaginal discomfort and. Estring dosage: Unk. During the same period patient was treated with SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ).

6811040-7 | Abdominal Pain
Adverse event was reported on Jan 20, 2009 by a Female patient taking Estring (View Usage) (Dosage: 2 Mg, Every 3 Months) was diagnosed with migraine (What is migraine?) and. Location: UNITED STATES , weighting 150.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?). During the same period patient was treated with ZETIA (Unk) (View Zetia Review and Zetia Label ), AMLODIPINE BESILATE (Unk) (View Amlodipine Besilate Review and Amlodipine Besilate Label ), CHLORTHALIDONE (Unk) (View Chlorthalidone Review and Chlorthalidone Label ).

6811039-0 | Fungal Infection
on Mar 20, 2009 Female patient from UNITED STATES , weighting 134.9 lb, was diagnosed with vulvovaginal dryness, vulvovaginal burning sensation and was treated with Estring (View Usage). After Estring was administered, patient had the following side effects: fungal infection (What is fungal infection?). Estring dosage: Unk. During the same period patient was treated with GABAPENTIN (Unk) (View Gabapentin Review and Gabapentin Label ), VALTREX (Unk) (View Valtrex Review and Valtrex Label ), ZOLPIDEM (Unk) (View Zolpidem Review and Zolpidem Label ), CHLORDIAZEPOXIDE/CLIDINIUM (Unk) (View Chlordiazepoxide/clidinium Review and Chlordiazepoxide/clidinium Label ).

6811038-9 | Vaginal Haemorrhage
on Jan 28, 2009 Female patient from UNITED STATES , weighting 179.9 lb, was treated with Estring (View Usage). Patient experienced the following unwanted or unexpected effects: vaginal haemorrhage. Estring dosage: Frequency: Q3m, Every Day;. During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6811037-7 | Vulvovaginal Burning Sensation, Vulvovaginal Discomfort
Patient was taking Estring (View Usage). Patient had the following side effects: vulvovaginal burning sensation, vulvovaginal discomfort on Mar 10, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 189.6 lb, was diagnosed with atrophic vulvovaginitis and. Estring dosage: 2 Mg, Every 3 Months. During the same period patient was treated with ESTRACE (View Estrace Review and Estrace Label ).